Table 2.
Characteristics and percentage chimerism of different biological samples at different time intervals
| Unique patient number | Sex/age at HSCT | Donor sex | Diagnosis | Type of transplantation | +21 to +31 days |
+3 months |
+6 months |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| blood percent donor type | buccal swab percent donor type | hair percent donor type | blood percent donor type | buccal swab percent donor type | hair percent donor type | blood percent donor type | buccal swab percent donor type | hair percent donor type | |||||
| 1 |
M/11 |
M |
Thalassemia |
BMT |
99.75 |
16.72 |
0 |
98.32 |
24.00 |
0 |
90.58 |
28.72 |
1.08 |
| 2 |
M/3 |
F |
CDA with thalassemia |
BMT |
100 |
23.00 |
1.34 |
100 |
25.98 |
2.16 |
100 |
27.00 |
4.45 |
| 3 |
M/39 |
F |
AML |
PBSCT |
100 |
12.3 |
0.56 |
100 |
15.4 |
1.21 |
100 |
18.3 |
2.00 |
| 4 |
M/18 |
F |
Severe aplastic anemia |
PBSCT |
100 |
12.60 |
1.98 |
100 |
14.33 |
2.32 |
100 |
24.97 |
3.67 |
| 5 |
M/35 |
F |
Severe aplastic anemia |
PBSCT |
100 |
9.2 |
0 |
100 |
10.1 |
0 |
100 |
11.3 |
0 |
| 6 |
M/11 |
M |
Aplastic anemia |
PBSCT |
100 |
10.5 |
0 |
100 |
11.6 |
0.67 |
100 |
12.3 |
0.98 |
| 7 |
F/45 |
F |
Severe aplastic anemia |
PBSCT |
100 |
15.9 |
2.38 |
100 |
16.4 |
2.62 |
100 |
19.2 |
3.54 |
| 8 |
M/8 |
F |
Thalassemia |
BMT |
100 |
20.5 |
4.38 |
100 |
25.1 |
5.12 |
100 |
29.7 |
8.00 |
| 9 |
M/31 |
M |
Refractive pure RBC aplasia |
PBSCT |
100 |
1.23 |
0 |
100 |
2.45 |
0 |
100 |
2.98 |
0 |
| 10 |
F/21 |
F |
Severe aplastic anemia |
PBSCT |
92.4 |
20.09 |
0.49 |
96.41 |
24.7 |
1.33 |
97.5 |
32.00 |
9.50 |
| 11 |
M/35 |
F |
Severe aplastic anemia |
PBSCT |
100 |
14.2 |
4.25 |
100 |
17.4 |
5.87 |
100 |
25.7 |
8.00 |
| 12 |
M/41 |
M |
Mixed phenotypic acute leukemia |
PBSCT |
100 |
2.56 |
0 |
100 |
3.59 |
0 |
100 |
5.36 |
0.67 |
| 13 |
M/8 |
F |
Very severe aplastic anemia |
BMT |
87 |
35.6 |
4.6 |
91 |
41.8 |
8.65 |
97 |
53.6 |
9,12 |
| 14 |
F/3 |
F |
Thalassemia |
BMT |
54.6 |
1..5 |
0 |
55.1 |
2.86 |
0 |
57 |
4.00 |
0 |
| 15 |
M/21 |
F |
Very severe aplastic anemia |
PBSCT |
100 |
6.73 |
0 |
100 |
10.6 |
0 |
100 |
12.3 |
0 |
| 16 |
M/15 |
M |
Severe aplastic anemia |
PBSCT |
93 |
38.5 |
6.78 |
95 |
48.9 |
9.76 |
99 |
54.5 |
10.09 |
| 17 |
M/22 |
M |
Very severe aplastic anemia |
PBSCT |
100 |
5.6 |
0 |
100 |
9.4 |
1.23 |
100 |
12.6 |
3.41 |
| 18 |
M/32 |
M |
CML |
PBSCT |
100 |
7.54 |
0 |
100 |
10.7 |
0 |
100 |
11.2 |
0 |
| 19 |
M/28 |
F |
Severe aplastic anemia |
PBSCT |
97 |
15.6 |
2.31 |
99 |
17.5 |
4.59 |
100 |
24.8 |
6.23 |
| 20 |
F/42 |
F |
Acute myeloid leukemia |
PBSCT |
100 |
22.1 |
5.12 |
100 |
24.00 |
6.00 |
100 |
25.1 |
9.49 |
| 21 |
M/42 |
M |
Aplastic anemia |
PBSCT |
100 |
2.56 |
0 |
100 |
5.34 |
0 |
100 |
7.8 |
0 |
| 22 |
M/8 |
F |
Thalassemia major |
BMT |
100 |
10.4 |
0.23 |
100 |
12.6 |
1.98 |
100 |
15.5 |
2.00 |
| 23 |
F/39 |
M |
CML |
PBSCT |
100 |
28.9 |
3.24 |
100 |
36.7 |
5.23 |
100 |
45.8 |
7.98 |
| 24 |
F/12 |
F |
Thalassemia major |
BMT |
55.00 |
0.5 |
0 |
51.2 |
1.11 |
0 |
46.9 |
1.9 |
0 |
| 25 |
M/17 |
F |
Severe aplastic anemia |
PBSCT |
100 |
21.6 |
0.76 |
100 |
26.8 |
2.89 |
100 |
30.4 |
5.71 |
| Mean (range) | 95.15 (54.6-100) | 14.76 (0.5-38.5) | 1.53 (0-6.78) | 95.44 (51.2-100) | 17.57 (1.11-48.9) | 2.46 (0-8.65) | 95.51 (46.9-100) | 21.48 (1.9-54.5) | 3.61 (0-10.09) | ||||
*BMT – bone marrow transplantation; PBSCT – peripheral blood stem cell transplantation; CDA – congenital dyserythropoietic anemia ; AML – acute myeloid leukemia; RBC – red blood cells.